Physician

Kaley Myer, M.D.

According to 2025 Medicare claims, Kaley Myer, M.D. (NPI: 1164869459) practices dermatology in the Olympia-Lacey-Tumwater, WA market, with the plurality of this provider's patient population coming from Thurston, WA. This provider's primary affiliated billing organization is DERMATOLOGY & ALLERGY SPECIALISTS (NPI: 1497755797; TIN: 912097219) and primary practice location at 98502-4957. Myer is affiliated with the PSW ACO (ACO ID: A5323), participating under the MSSP model.

Myer's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,528 traditional Medicare patients, billed 8,358 HCPCS/CPT codes, and received $440,030 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 876 prescription claims across 386 beneficiaries totaling $414,930 in drug costs, led by Rinvoq (Upadacitinib). Open Payments data shows 34 records totaling $320. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $29,452 to $440,030. Similarly, Part D prescription costs have risen steadily, from $17,527 to $414,930. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$231K$462K2017 Medicare payment: $29,452 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $160,970 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $284,015 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $268,983 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $312,552 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $347,273 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $461,853 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $440,030 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017148374$29,452
20186702,643$160,970
20198584,698$284,015
20208185,215$268,983
20218695,671$312,552
20229886,981$347,273
20231,1759,146$461,853
20241,5288,358$440,030

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$207K$415K2015 Drug cost: $17,527 (USD; Tot_Drug_Cst)2016 Drug cost: $20,668 (USD; Tot_Drug_Cst)2017 Drug cost: $41,826 (USD; Tot_Drug_Cst)2018 Drug cost: $83,634 (USD; Tot_Drug_Cst)2019 Drug cost: $139,794 (USD; Tot_Drug_Cst)2020 Drug cost: $199,862 (USD; Tot_Drug_Cst)2021 Drug cost: $205,406 (USD; Tot_Drug_Cst)2022 Drug cost: $159,606 (USD; Tot_Drug_Cst)2023 Drug cost: $286,700 (USD; Tot_Drug_Cst)2024 Drug cost: $414,930 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201567179$17,527
201685240$20,668
201796205$41,826
2018206378$83,634
2019298611$139,794
2020237538$199,862
2021279688$205,406
2022260577$159,606
2023387888$286,700
2024386876$414,930

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths482557$74
11102Biopsy of related skin growth, first growth426513$58
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more8541,073$58
17000Destruction of precancer skin growth, 1 growth656834$33
17003Destruction of precancer skin growth, 2-14 growths4892,654$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RinvoqUpadacitinib17690$138,849
Enbrel SureclickEtanercept11310$91,490
Dupixent PenDupilumab19534$71,553
FluorouracilFluorouracil712,055$4,155
Clobetasol PropionateClobetasol Propionate501,486$2,599

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.34$320ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Kaley Myer, M.D.?

Tedicare shows public-source Medicare data for Kaley Myer, M.D. (NPI 1164869459), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kaley Myer, M.D. have ACO affiliation data?

Kaley Myer, M.D. is shown with ACO affiliation data for PSW ACO (MSSP, ACO ID A5323).

What billing organization is linked to Kaley Myer, M.D.?

Kaley Myer, M.D. is linked to DERMATOLOGY & ALLERGY SPECIALISTS (billing NPI 1497755797) in the available physician profile data.

Does Kaley Myer, M.D. have Open Payments data?

Kaley Myer, M.D. has 34 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.